Brain Scientific Inc.
BRSF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $5 | $11 | $38 | $160 |
| % Growth | -55.6% | -70.3% | -75.9% | – |
| Cost of Goods Sold | $12 | $4 | $38 | $107 |
| Gross Profit | -$6 | $7 | $0 | $53 |
| % Margin | -127.1% | 64.5% | 1.3% | 33.2% |
| R&D Expenses | $78 | $57 | $83 | $85 |
| G&A Expenses | $1,293 | $3,803 | $1,896 | $1,672 |
| SG&A Expenses | $1,419 | $3,969 | $2,110 | $1,863 |
| Sales & Mktg Exp. | $126 | $165 | $214 | $191 |
| Other Operating Expenses | $0 | $0 | $0 | $7 |
| Operating Expenses | $1,497 | $4,025 | $2,193 | $1,948 |
| Operating Income | $389 | -$4,018 | -$2,192 | -$1,895 |
| % Margin | 7,661.5% | -35,147.7% | -5,699.6% | -1,187.3% |
| Other Income/Exp. Net | -$1,730 | -$419 | -$321 | -$265 |
| Pre-Tax Income | -$3,233 | -$4,437 | -$2,514 | -$2,160 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,948 | -$4,153 | -$1,221 | -$2,160 |
| % Margin | -77,714.6% | -36,323.8% | -3,173.6% | -1,353.5% |
| EPS | -3.18 | -3.35 | -1.7 | -3.63 |
| % Growth | 5.1% | -97.1% | 53.2% | – |
| EPS Diluted | -3.18 | -3.35 | -1.7 | -3.63 |
| Weighted Avg Shares Out | 1,243 | 1,240 | 719 | 595 |
| Weighted Avg Shares Out Dil | 1,243 | 1,240 | 719 | 595 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,016 | $703 | $1,614 | $272 |
| Depreciation & Amortization | $202 | $201 | $201 | $201 |
| EBITDA | -$103 | -$4,086 | -$698 | -$1,704 |
| % Margin | -2,031% | -35,739.3% | -1,815.4% | -1,067.6% |